- Home
- PRPH vs CING Comparison
PRPH vs CING Comparison
Compare PRPH & CING Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRPH
- CING
- Stock Information
- Founded
- PRPH 1989
- CING 2012
- Country
- PRPH United States
- CING United States
- Employees
- PRPH N/A
- CING N/A
- Industry
- PRPH Biotechnology: Pharmaceutical Preparations
- CING Biotechnology: Pharmaceutical Preparations
- Sector
- PRPH Health Care
- CING Health Care
- Exchange
- PRPH Nasdaq
- CING Nasdaq
- Market Cap
- PRPH 10.7M
- CING 14.4M
- IPO Year
- PRPH 1997
- CING 2021
- Fundamental
- Price
- PRPH $0.43
- CING $3.63
- Analyst Decision
- PRPH
- CING Strong Buy
- Analyst Count
- PRPH 0
- CING 3
- Target Price
- PRPH N/A
- CING $16.00
- AVG Volume (30 Days)
- PRPH 27.1M
- CING 100.4K
- Earning Date
- PRPH 03-18-2025
- CING 05-07-2025
- Dividend Yield
- PRPH N/A
- CING N/A
- EPS Growth
- PRPH N/A
- CING N/A
- EPS
- PRPH N/A
- CING N/A
- Revenue
- PRPH $12,753,000.00
- CING N/A
- Revenue This Year
- PRPH $36.93
- CING N/A
- Revenue Next Year
- PRPH $132.05
- CING N/A
- P/E Ratio
- PRPH N/A
- CING N/A
- Revenue Growth
- PRPH N/A
- CING N/A
- 52 Week Low
- PRPH $0.22
- CING $1.80
- 52 Week High
- PRPH $7.48
- CING $20.83
- Technical
- Relative Strength Index (RSI)
- PRPH 48.83
- CING 33.93
- Support Level
- PRPH $0.31
- CING $3.47
- Resistance Level
- PRPH $0.46
- CING $3.99
- Average True Range (ATR)
- PRPH 0.07
- CING 0.29
- MACD
- PRPH 0.00
- CING -0.03
- Stochastic Oscillator
- PRPH 46.28
- CING 17.88
About PRPH ProPhase Labs Inc. (DE)
ProPhase Labs Inc is a diversified company that offers a range of services including diagnostic testing, genomics testing and contract manufacturing. Its operating segments include Diagnostic services and Consumer products. The Diagnostic segment provides COVID-19 diagnostic information services to a broad range of customers in the United States, including health plans, third-party payers and government organizations. The Consumer products segment is engaged in the research, development, manufacture, distribution, marketing and sale of OTC consumer healthcare products and dietary supplements in the United States and also provide personal genomics products and services.
About CING Cingulate Inc.
Cingulate Inc is a clinical-stage biopharmaceutical company utilizing its proprietary precision timed-release drug delivery platform to build and advance a pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes. The company focuses on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety, and identifying and evaluating additional therapeutic areas to use PTR technology to develop future product candidates.